Blauvelt, A, B Strober, R Langley, D Burge, L Pisenti, M Yassine, S Kavanagh, C Arendt, R Rolleri, and K Reich. “Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks’ Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S16. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/307.